Opinion
Accepted on 08 Nov 2024
Human-specific gene ARHGAP11B – potentially an additional tool in the treatment of neurodegenerative diseases?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1465647
Volumes
8 Publications
Hypothesis and Theory
Published on 18 Sep 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1461151
- 585 views
Review
Published on 06 Sep 2024
Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1426454
- 1,117 views
Editorial
Published on 03 Jul 2024
Editorial: Mitochondrial dysfunction affects mechano-energetic coupling in heart failure
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1433102
- 687 views
Original Research
Published on 29 Apr 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1389456
- 1,915 views
Editorial
Published on 27 Feb 2024
Editorial: Celebrating the 200th mendel’s anniversary: gene-targeted diagnostics and therapies for cancer
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1366963
- 1,394 views
Review
Published on 01 Feb 2024
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1310002
- 6,957 views
- 1 citation
Original Research
Published on 26 Jan 2024
Combined analysis of host IFN-γ, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1345510
- 2,016 views
- 1 citation